Skip to main content

The association of matrix metalloproteinase-1 genetic polymorphism (−1607 1G>2G) with colorectal cancer: a meta-analysis

Tumor Biology volume 34, pages 3801–3806 (2013)Cite this article

Abstract

Several case–control studies on the relation between matrix metalloproteinase (MMP)-1 gene −1607 1G>2G polymorphism and colorectal cancer do not have similar conclusions. The previous two meta-analyses focusing on the same issue also were inconsistent. To further evaluate the relation between the MMP-l gene polymorphism and colorectal cancer, we selected eight case–control studies related to MMP-1 gene polymorphism and colorectal cancer by searching MEDLINE, Embase, CANCERLIT, American Association for Cancer Research, Chinese Biomedical Literature Database, Chinese CNKI, and Wanfang database. Q test and I 2 test were used to test the heterogeneity. We utilized the random effects model to calculate the odds ratio (OR), 95 % confidence interval (CI), and the overall effect of P value using the RevMan 5.2 software. The present study included 1,403 patients with colorectal cancer and 1,754 healthy control subjects. Both −1607 2G/2G genotype carriers [OR = 1.59, 95 % CI (1.27–2.01); P < 0.001] and the −1607 2G allele carriers [OR = 1.26, 95 % CI (1.05–1.51); P = 0.01] were found to have an increased risk of colorectal cancer. Therefore, we concluded that MMP-1 −1607 1G>2G polymorphism was associated with colorectal cancer.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. Hutter CM, Chang-Claude J, Slattery ML, Pflugeisen BM, Lin Y, Duggan D, et al. Characterization of gene–environment interactions for colorectal cancer susceptibility loci. Cancer Res. 2012;72(8):2036–44.

    PubMed  Article  CAS  Google Scholar 

  2. Theodoratou E, Montazeri Z, Hawken S, Allum GC, Gong J, Tait V, et al. Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer. J Natl Cancer Inst. 2012;104(19):1433–57.

    PubMed  Article  CAS  Google Scholar 

  3. Zhong R, Liu L, Zou L, Sheng W, Zhu B, Xiang H, et al. Genetic variations in the TGFβ signaling pathway, smoking and risk of colorectal cancer in a Chinese population. Carcinogenesis. 2013;34(4):936–42.

    PubMed  Article  CAS  Google Scholar 

  4. Nissar S, Lone TA, Banday MZ, Rasool R, Chowdri NA, Parray FQ, et al. Arg399Gln polymorphism of XRCC1 gene and risk of colorectal cancer in Kashmir: a case control study. Oncol Lett. 2013;5(3):959–63.

    PubMed  CAS  Google Scholar 

  5. Ladero JM, Agúndez JA, Martínez C, Amo G, Ayuso P, García-Martín E. Analysis of the functional polymorphism in the cytochrome P450 CYP2C8 gene rs11572080 with regard to colorectal cancer risk. Front Genet. 2012;3:278.

    PubMed  CAS  Google Scholar 

  6. Sagne C, Marcel V, Amadou A, Hainaut P, Olivier M, Hall J. A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects. Cell Death Dis. 2013;4:e492. doi:10.1038/cddis.2013.24.

    PubMed  Article  CAS  Google Scholar 

  7. Liu Y, Li L, Qi H, Gao Y, Liu S, Xu C. Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis. PLoS One. 2013;8(2):e54081.

    PubMed  Article  CAS  Google Scholar 

  8. Piao Y, Liu Z, Ding Z, Xu L, Guo F, Sun Q, et al. EGF +61A&gt;G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis. Gene. 2013;519(1):26–33. doi:10.1016/j.gene.2013.01.057. Epub 2013 Feb 9.

    PubMed  Article  CAS  Google Scholar 

  9. Gomes EG, Jucá MJ, de Menezes HL, Nunes BL, Costa H, Lima Fde O, et al. Correlation between the immunohistochemical expressions of MMP-1, MMP-7 and VEGF and prognostic factors in colorectal adenocarcinoma. Acta Cir Bras. 2009;24(4):303–10.

    PubMed  Google Scholar 

  10. Bendardaf R, Buhmeida A, Ristamäki R, Syrjänen K, Pyrhönen S. MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases. Scand J Gastroenterol. 2007;42(12):1473–8.

    PubMed  Article  CAS  Google Scholar 

  11. Hettiaratchi A, Hawkins NJ, McKenzie G, Ward RL, Hunt JE, Wakefield D, et al. The collagenase-1 (MMP-1) gene promoter polymorphism −1607/2G is associated with favourable prognosis in patients with colorectal cancer. Br J Cancer. 2007;96(5):783–92.

    PubMed  Article  CAS  Google Scholar 

  12. Elander N, Söderkvist P, Fransén K. Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res. 2006;26(1B):791–5.

    PubMed  CAS  Google Scholar 

  13. Zinzindohoué F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A, et al. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. Clin Cancer Res. 2005;11(2 Pt 1):594–9.

    PubMed  Google Scholar 

  14. Roeb E, Arndt M, Jansen B, Schumpelick V, Matern S. Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas. Int J Colorectal Dis. 2004;19(6):518–24.

    PubMed  Article  Google Scholar 

  15. Bendardaf R, Lamlum H, Vihinen P, Ristamäki R, Laine J, Pyrhönen S. Low collagenase-1 (MMP-1) and MT1-MMP expression levels are favourable survival markers in advanced colorectal carcinoma. Oncology. 2003;65(4):337–46.

    PubMed  Article  CAS  Google Scholar 

  16. Araki A, Hazama S, Oka M, Hinoda Y. Polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 in colorectal cancer. Nihon Rinsho. 2003;61 Suppl 7:229–32.

    PubMed  Google Scholar 

  17. Behrens P, Mathiak M, Mangold E, Kirdorf S, Wellmann A, Fogt F, et al. Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers. Int J Cancer. 2003;107(2):183–8.

    PubMed  Article  CAS  Google Scholar 

  18. Horiuchi S, Yamamoto H, Min Y, Adachi Y, Itoh F, Imai K. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer. J Pathol. 2003;200(5):568–76.

    PubMed  Article  CAS  Google Scholar 

  19. Hinoda Y, Okayama N, Takano N, Fujimura K, Suehiro Y, Hamanaka Y, et al. Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int J Cancer. 2002;102(5):526–9.

    PubMed  Article  CAS  Google Scholar 

  20. Biondi ML, Turri O, Leviti S, Seminati R, Cecchini F, Bernini M, et al. MMP1 and MMP3 polymorphisms in promoter regions and cancer. Clin Chem. 2000;46:2023–4.

    PubMed  CAS  Google Scholar 

  21. Lievre A, Milet J, Carayol J, et al. Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma. BMC Cancer. 2006;6:270–7.

    PubMed  Article  Google Scholar 

  22. Xu EP, Lai MD, Lu BJ, Xing XM, Huang Q. No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in Chinese. Dis Colon Rectum. 2006;49:1439–44.

    PubMed  Article  Google Scholar 

  23. Woo M, Park K, Nam J, Kim JC. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol. 2007;22:1064–70.

    PubMed  Article  CAS  Google Scholar 

  24. Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, et al. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin Cancer Res. 2002;8:3820–3.

    PubMed  CAS  Google Scholar 

  25. Kouhkan F, Motovali-Bashi M, Hojati Z. The influence of interstitial collagenas-1 genotype polymorphism on colorectal cancer risk in Iranian population. Cancer Invest. 2008;26:836–42.

    PubMed  Article  CAS  Google Scholar 

  26. Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, Guagnellini E, et al. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res. 2001;7(8):2344–6.

    PubMed  CAS  Google Scholar 

  27. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 1998;58:5321–5.

    PubMed  CAS  Google Scholar 

  28. Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, Kudo R, et al. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res. 1999;59:4225–7.

    PubMed  CAS  Google Scholar 

  29. Peng B, Cao L, Wang W, Xian L, Jiang D, Zhao J, et al. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case–control studies. Mutagenesis. 2010;25(1):41–8.

    PubMed  Article  CAS  Google Scholar 

  30. Song H, Peng JS, Wu XB, Du YP. Meta-analysis of matrix metalloproteinase-1 gene polymorphism and susceptibility to colorectal cancer. Lingnan Modern Clin Surg. 2010;10:321–4.

    Google Scholar 

  31. Jung JW, Cho SD, Ahn NS, Yang SR, Park JS, Jo EH, et al. Effects of the histone deacetylases inhibitors sodium butyrate and trichostatin A on the inhibition of gap junctional intercellular communication by H2O2- and 12-O-tetradecanoylphorbol-13-acetate in rat liver epithelial cells. Cancer Lett. 2006;241(2):301–8.

    PubMed  Article  CAS  Google Scholar 

  32. Maeta H, Ohgi S, Terada T. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas. Virchows Arch. 2001;438(2):121–8.

    PubMed  Article  CAS  Google Scholar 

  33. Ranganathan AC, Nelson KK, Rodriguez AM, et al. Manganese superoxide dismutase signals matrix metalloproteinase expression via H202-dependent ERK1/2 activation. J Biol Chem. 2001;276:14264–70.

    PubMed  CAS  Google Scholar 

  34. Murray GI, Duncan ME, ONeil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med. 1996;2:461–2.

    PubMed  Article  CAS  Google Scholar 

  35. Baker EA, Bergin FG, Leaper DJ. Matrix metal1oproteinases, their tissue inhibitors and colorectal cancer staging. Br J Surg. 2000;87:1215–21.

    PubMed  Article  CAS  Google Scholar 

  36. Shiozawa J, Ito M, Kakayama M, et al. Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Mod Pathol. 2000;13:925–33.

    PubMed  Article  CAS  Google Scholar 

Download references

Conflicts of interest

None

Author information

Affiliations

  1. Department of General Surgery, Tongji Hospital of Tongji University, Shanghai, 200065, China

    Shu-Rong Ji, Jian-Jun Sun, Xin-Ping Li & Wen-Fang Liu

  2. Central Laboratory, Tongji Hospital of Tongji University, Shanghai, 200065, China

    Yi Zhang

Authors
  1. Shu-Rong Ji
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jian-Jun Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xin-Ping Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wen-Fang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wen-Fang Liu.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ji, SR., Sun, JJ., Li, XP. et al. The association of matrix metalloproteinase-1 genetic polymorphism (−1607 1G>2G) with colorectal cancer: a meta-analysis. Tumor Biol. 34, 3801–3806 (2013). https://doi.org/10.1007/s13277-013-0964-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-0964-z

Keywords

  • Colorectal cancer
  • Matrix metalloproteinase-l
  • Gene polymorphism
  • Meta-analysis